✦ LIBER ✦

Mechanism of Synergistic Antitumor Effect of Sorafenib and Interferon-α on Treatment of Renal Cell Carcinoma

✍ Scribed by Takeuchi, Ario; Eto, Masatoshi; Tatsugami, Katsunori; Yamada, Hisakata; Oki, Toshihiro; Kiyoshima, Keijiro; Yoshikai, Yasunobu; Naito, Seiji

Book ID: 122655134
Publisher: Lippincott Williams and Wilkins
Year: 2010
Tongue: English
Weight: 788 KB
Volume: 184
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2010.07.033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MECHANISTIC ANALYSIS OF SYNERGISTIC ANTI

MECHANISTIC ANALYSIS OF SYNERGISTIC ANTITUMOR EFFECTS OF INTERFERON-α AND SORAFENIB IN RENAL CELL CARCINOMA

✍ Eto, Masatoshi; Takeuchi, Ario; Kamiryo, Yoriyuki; Tatsugami, Katsunori; Naito, 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 69 KB

Synergistic antitumor effects of tumor n

Synergistic antitumor effects of tumor necrosis factor-α, -β and interferon-γ on mouse Lewis lung Carcinoma

✍ Y. Nishiyama 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 85 KB

298 CLUSTERIN INHIBITION USING OGX-011 S

298 CLUSTERIN INHIBITION USING OGX-011 SYNERGISTICALLY ENHANCES ANTITUMOR ACTIVITY OF SORAFENIB IN A HUMAN RENAL CELL CARCINOMA MODEL

✍ Kusuda, Yuji; Miyake, Hideaki; Gleave, Martin; Fujisawa, Masato 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 50 KB

Cost-Effectiveness of Sorafenib for Seco

Cost-Effectiveness of Sorafenib for Second-Line Treatment of Advanced Renal Cell Carcinoma

✍ Martin Hoyle; Colin Green; Jo Thompson-Coon; Zulian Liu; Karen Welch; Tiffany Mo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

Antitumor Effects of Aminobisphosphonate

Antitumor Effects of Aminobisphosphonates on Renal Cell Carcinoma Cell Lines

✍ Pandha, Hardev; Birchall, Lindsay; Meyer, Brendan; Wilson, Natalie; Relph, Kate; 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 740 KB

Where does the combination of sorafenib

Where does the combination of sorafenib and interferon in renal cell carcinoma stand?

✍ Keith T. Flaherty 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Sorafenib can be combined safely with interferon, but the results of a recent randomized, phase 2 trial cast doubt on the value of further evaluating this combination. The renal cell carcinoma field continues to wrestle with the value of combining “targeted” therapies with cytokines.